XML 23 R13.htm IDEA: XBRL DOCUMENT
v3.25.3

Intangible Assets | 9 Months Ended
--- | ---
Sep. 30, 2025
Intangible Assets, Net (Excluding Goodwill) [Abstract] |
Intangible Assets | 6. Intangible Assets The following table presents details of the Company’s acquired intangible assets as of September 30, 2025 and December 31, 2024 (in thousands):
As of September 30, 2025 |  |  |  | Gross Carrying Amount |  | Accumulated Amortization |  | Net
Finite-lived intangible assets: |  |  |  |  |  |  |  |
Customer relationships |  |  |  | $ | 6,997 |  |  | $ | (3,848) |  |  | $ | 3,149 |
Trade secrets and processes |  |  |  | 5,256 |  |  | (2,037) |  |  | 3,219 |
Total intangible assets |  |  |  | $ | 12,253 |  |  | $ | (5,885) |  |  | $ | 6,368 |
During the nine months ended September 30, 2025, the Company disposed of intangible assets related to its immersive healthcare business that had been previously impaired during the year ended December 31, 2024, resulting in the write-off of developed technology and the corresponding accumulated amortization of $83.3 million.
As of December 31, 2024 |  |  |  | Gross Carrying Amount |  | Accumulated Amortization |  | Net
Finite-lived intangible assets: |  |  |  |  |  |  |  |
Developed technology(1) |  |  |  | $ | 83,289 |  |  | $ | (83,289) |  |  | $ | — |
Customer relationships |  |  |  | 6,192 |  |  | (3,095) |  |  | 3,097 |
Trade secrets and processes |  |  |  | 5,256 |  |  | (1,840) |  |  | 3,416 |
Total intangible assets |  |  |  | $ | 94,737 |  |  | $ | (88,224) |  |  | $ | 6,513 |
(1)During the year ended December 31, 2024, the Company recorded an impairment of developed technology charge of $58.9 million included within accumulated amortization in the table above. Refer to Note “4. Impairment and Restructuring Costs of Immersive Healthcare Asset Group” for more information. The gross carrying amount and accumulated amortization of the customer relationships are the only intangible assets subject to foreign currency translation effects. The Company’s $5.3 million trade secrets and processes intangible asset was recognized in connection with a royalty buyout agreement in 2018. The following table presents the amortization recorded related to the Company’s finite-lived intangible assets for the three and nine months ended September 30, 2025 and 2024 (in thousands):
|  | Three Months Ended September 30, |  | Nine Months Ended September 30,
|  | 2025 |  | 2024 |  | 2025 |  | 2024
Cost of revenue |  | $ | 66 |  |  | $ | 66 |  |  | $ | 197 |  |  | $ | 197 |
Sales, general and administrative(1) |  | 116 |  |  | 110 |  |  | 333 |  |  | 5,083 |
Total |  | $ | 182 |  |  | $ | 176 |  |  | $ | 530 |  |  | $ | 5,280 |
(1)This does not include the impairment charge of $58.9 million related to the Company’s immersive healthcare developed technology during the three months ended June 30, 2024. Refer to Note “4. Impairment and Restructuring Costs of Immersive Healthcare Asset Group” for more information.

X
- Definition The entire disclosure for all or part of the information related to intangible assets. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/350-30/tableOfContent Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482665/350-30-50-4 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 985 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 985 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/985-20/tableOfContent + Details
Name: | us-gaap_IntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration